Jammu, India

Sanghapal Damodhar Sawant

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanghapal Damodhar Sawant. Retrieved from https://idiyas.com/inventor/sanghapal-damodhar-sawant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 9.7

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Jammu Tawi, IN (2013)
  • Jammu, IN (2015 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Sanghapal Damodhar Sawant

Introduction

Sanghapal Damodhar Sawant is a notable inventor based in Jammu, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various medical conditions. With a total of 4 patents to his name, his work has the potential to impact the treatment of erectile dysfunction and tuberculosis.

Latest Patents

One of his latest patents is titled "Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof." This invention relates to Pyrazolopyrimidinone compounds that act as PDE5 inhibitors, demonstrating better IC values, good in vivo efficacy, and a favorable pharmacokinetic profile. These designer compounds have shown nanomolar potency in PDE5 inhibitory activity and can be utilized in treating male erectile dysfunction.

Another significant patent is "6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof." This invention introduces a new generation of agents containing 6-nitro-2,3-dihydronitroimidazooxazoles, which are effective in treating multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). These agents exhibit acceptable pharmacokinetic properties and can work synergistically with known anti-tubercular drugs.

Career Highlights

Sanghapal Damodhar Sawant is affiliated with the Council of Scientific & Industrial Research, where he conducts his research and development activities. His work focuses on creating innovative solutions to pressing health issues, particularly in the pharmaceutical sector.

Collaborations

He has collaborated with notable colleagues such as Ram Asrey Vishwakarma and Amit Nargotra, contributing to the advancement of research in his field.

Conclusion

Sanghapal Damodhar Sawant's contributions to pharmaceutical innovations highlight his commitment to improving healthcare through research and development. His patents reflect a dedication to addressing significant medical challenges, particularly in the treatment of impotence and tuberculosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…